Press release

Wellcome Trust renews Biomedical Research Partnership in Ireland

Science Foundation Ireland (SFI), the Health Research Board (HRB) and the Wellcome Trust have announced the renewal of the SFI-HRB-Wellcome Trust Biomedical Research Partnership.

The partnership, established in 2010, has provided funding of over €4 million for biomedical and clinical science research in Ireland.

Researchers in the National University of Ireland Galway, Trinity College Dublin and University College Dublin have been supported by the partnership to date. Research that has been supported includes investigation of the dietary factors influencing cardiovascular disease, cell division in cancer and memory function.

Commenting on the partnership renewal, Minister for Skills, Research and Innovation Damien English, T.D. said, "The SFI-HRB-Wellcome Trust Biomedical Research Partnership provides support to researchers in Ireland to expand and deepen their investigations into some of the most pressing biomedical and clinical research questions in health. The joint funding will continue to support the best scientists and clinical researchers in Ireland, will continue to boost Ireland’s biomedical research credentials, attracting investment and ultimately creating jobs."

Dr Jeremy Farrar, Director of the Wellcome Trust said, "The Wellcome Trust is pleased to continue our longstanding and productive relationship with the Irish research community. We are committed to supporting creative, innovative and ambitious biomedical researchers, at all stages of their career, to deliver excellent science. This partnership with Science Foundation Ireland and the Health Research Board allows us to maximise our support to biomedical researchers in Ireland and builds on the success of those that have been funded previously. Supporting Irish biomedical researchers also complements our other activities in Ireland including public engagement, medical humanities and translational research."

Dr Graham Love, Chief Executive of the Health Research Board, said, "Health research with real meaning for patients requires meaningful collaboration. That is what we have here: an excellent, international partnership that will deliver for patients."

Professor Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland, said, "Since its inception, the SFI-HRB-Wellcome Trust Biomedical Research Partnership has supported important research projects in areas such as cancer research, heart disease and brain function. Its expansion will see Ireland’s expertise in biomedical and clinic research deepened and through additional funding streams, will open up new opportunities for Irish researchers, helping early career researchers move towards research independence. The involvement of the Wellcome Trust is hugely significant in that it highlights the international recognition given to Ireland’s biomedical sector, a sector which is of strategic importance to our economy and society."